LAB INVESTOR ALERT: Julie & Holleman LLP Announces Investigation of Proposed Merger Between Standard BioTools and SomaLogic
NEW YORK, Oct. 4, 2023 /PRNewswire/ -- Shareholder rights law firm Julie & Holleman LLP is investigating potential breaches of fiduciary duty relating to the proposed merger between Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic, Inc. (Nasdaq: SLGC).
For a no-cost consult and to learn more about our investigation, please click here or visit: https://julieholleman.com/?p=3147
Standard BioTools, previously known as Fluidigm Corporation, is a company that develops, manufactures, and sells technologies that help biomedical researchers develop medicines faster and better. SomaLogic is a leading commercial-stage proteomics company.
On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools shareholders will own 43% of the combined company, with SomaLogic's current shareholders owning the remaining 57%.
Julie & Holleman, a nationally recognized shareholder rights firm, is investigating potential breaches of fiduciary duty and has already identified several areas of concern.
If you would like more information about Julie & Holleman's investigation, or about the acquisition in general, please contact W. Scott Holleman by email at scott@julieholleman.com or by telephone at (929) 415-1020. You may also visit the firm's website by clicking here.
About the Firm
Julie & Holleman is a boutique law firm that focuses on shareholder litigation, including derivative actions, mergers and acquisitions cases, securities fraud class actions, and corporate investigations. The firm's attorneys litigate in state and federal courts across the nation and have helped secure hundreds of millions of dollars for aggrieved companies and their shareholders. For more information about the firm, please visit https://www.julieholleman.com/. This notice may constitute attorney advertising.
CONTACT INFORMATION
Julie & Holleman LLP
W. Scott Holleman, Esq.
157 East 86th Street
4th Floor
New York, NY 10028
(929) 415-1020
www.julieholleman.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lab-investor-alert-julie--holleman-llp-announces-investigation-of-proposed-merger-between-standard-biotools-and-somalogic-301947275.html
SOURCE Julie & Holleman LLP
